Loading...
Does tumor profile in gastric and gastroesophageal (GE) junction cancer justify off-label use of targeted therapy?—a narrative review
Despite significant therapeutic progress, gastric cancer remains among the most deadly forms of cancer encountered in clinical practice, and this remains true even in the context of declining incidence. Outcomes in advanced disease remain poor and therapy is rarely curative in this setting. As our u...
Saved in:
| Published in: | Ann Transl Med |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
AME Publishing Company
2020
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7575969/ https://ncbi.nlm.nih.gov/pubmed/33145329 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm-20-3510 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|